Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Technology Scientific & Technical Instruments

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > THRM price will move toward 0.50+ by this afternoon

<< Previous

Bullboard Posts

Next >>

Comment by Moemoney42on Mar 18, 2021 10:46am

83 Views

Post# 32825466

RE:THRM price will move toward 0.50+ by this afternoon

flight100 wrote: Now that THEM news is being dissimenated, I highly believe that we will see 0.50+ by this afternoon. Having 100% accuracy is not something that a company claims and the market doesn't like it :-)

Well all I can say is good luck with your buys today.. no way I'd put that kind of money in a long shot that has tripped on its own execution sooo many times...

And by the way.. as far as I know.. all the existing tests on the market can claim 100% accuracy 7 days into symptoms... what happened to the big claim of testing for asymptomatic patients.. now that's not the deal.. see what I mean.. QUOTE:

"Mr. Fia went on to say, "Recent lab results of our locked test showed 100% sensitivity and 100% specificity in most patients when tested within 7 days of onset of symptoms. This is the test that will be entering the performance study."

So tell me.. now can a test be 100% when its only in "MOST" patients..?????? This tells me its NOT 100% otherwise it would read "ALL PATIENTS" wouldn't it...????

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season